LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
LNTH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LNTH is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make LNTH suitable for value and quality investing!
1. Profitability
1.1 Basic Checks
LNTH had positive earnings in the past year.
In the past year LNTH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
Each year in the past 5 years LNTH had a positive operating cash flow.
1.2 Ratios
LNTH has a Return On Assets of 12.37%. This is amongst the best in the industry. LNTH outperforms 94.65% of its industry peers.
With an excellent Return On Equity value of 21.85%, LNTH belongs to the best of the industry, outperforming 93.58% of the companies in the same industry.
LNTH's Return On Invested Capital of 18.93% is amongst the best of the industry. LNTH outperforms 97.33% of its industry peers.
LNTH had an Average Return On Invested Capital over the past 3 years of 16.25%. This is significantly above the industry average of 7.89%.
The 3 year average ROIC (16.25%) for LNTH is below the current ROIC(18.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROIC | 18.93% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
1.3 Margins
LNTH's Profit Margin of 16.55% is amongst the best of the industry. LNTH outperforms 93.58% of its industry peers.
In the last couple of years the Profit Margin of LNTH has grown nicely.
LNTH has a better Operating Margin (29.30%) than 98.40% of its industry peers.
LNTH's Operating Margin has improved in the last couple of years.
LNTH has a Gross Margin of 64.04%. This is in the better half of the industry: LNTH outperforms 66.31% of its industry peers.
In the last couple of years the Gross Margin of LNTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% |
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LNTH is creating value.
The number of shares outstanding for LNTH remains at a similar level compared to 1 year ago.
LNTH has more shares outstanding than it did 5 years ago.
LNTH has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.26 indicates that LNTH is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.26, LNTH belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
The Debt to FCF ratio of LNTH is 1.20, which is an excellent value as it means it would take LNTH, only 1.20 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.20, LNTH belongs to the top of the industry, outperforming 90.37% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that LNTH is not too dependend on debt financing.
LNTH has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: LNTH outperforms 41.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Altman-Z | 6.26 |
ROIC/WACC2.27
WACC8.35%
2.3 Liquidity
LNTH has a Current Ratio of 5.74. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.74, LNTH belongs to the best of the industry, outperforming 81.28% of the companies in the same industry.
LNTH has a Quick Ratio of 5.46. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
LNTH has a Quick ratio of 5.46. This is amongst the best in the industry. LNTH outperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 |
3. Growth
3.1 Past
LNTH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.64%.
Measured over the past years, LNTH shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.10% on average per year.
The Revenue has grown by 12.53% in the past year. This is quite good.
LNTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.59% yearly.
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
3.2 Future
Based on estimates for the next years, LNTH will show a small growth in Earnings Per Share. The EPS will grow by 7.20% on average per year.
Based on estimates for the next years, LNTH will show a small growth in Revenue. The Revenue will grow by 7.69% on average per year.
EPS Next Y0.57%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.15, LNTH is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 93.05% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. LNTH is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.64, the valuation of LNTH can be described as very reasonable.
92.51% of the companies in the same industry are more expensive than LNTH, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.89. LNTH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.15 | ||
| Fwd PE | 10.64 |
4.2 Price Multiples
91.44% of the companies in the same industry are more expensive than LNTH, based on the Enterprise Value to EBITDA ratio.
LNTH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LNTH is cheaper than 95.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.76 | ||
| EV/EBITDA | 10.12 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LNTH does not grow enough to justify the current Price/Earnings ratio.
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)21.15
PEG (5Y)0.29
EPS Next 2Y5.56%
EPS Next 3Y9.03%
5. Dividend
5.1 Amount
LNTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
80.42
+0.8 (+1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners115.61%
Inst Owner Change-57.96%
Ins Owners1.3%
Ins Owner Change3.24%
Market Cap5.56B
Analysts82.11
Price Target131.89 (64%)
Short Float %13.52%
Short Ratio7.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.03%
Min EPS beat(2)-9.67%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)-1.14%
Min EPS beat(4)-9.67%
Max EPS beat(4)7.07%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)10
Avg EPS beat(12)11.67%
EPS beat(16)14
Avg EPS beat(16)27.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.13%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)1%
Revenue beat(12)9
Avg Revenue beat(12)2.39%
Revenue beat(16)13
Avg Revenue beat(16)4.62%
PT rev (1m)-4.16%
PT rev (3m)-3.78%
EPS NQ rev (1m)-1.08%
EPS NQ rev (3m)-2.96%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-4.97%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.15 | ||
| Fwd PE | 10.64 | ||
| P/S | 3.62 | ||
| P/FCF | 11.76 | ||
| P/OCF | 10.6 | ||
| P/B | 4.78 | ||
| P/tB | 5.86 | ||
| EV/EBITDA | 10.12 |
EPS(TTM)6.62
EY8.23%
EPS(NY)7.55
Fwd EY9.39%
FCF(TTM)6.84
FCFY8.5%
OCF(TTM)7.59
OCFY9.44%
SpS22.21
BVpS16.83
TBVpS13.72
PEG (NY)21.15
PEG (5Y)0.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROCE | 24.91% | ||
| ROIC | 18.93% | ||
| ROICexc | 39.39% | ||
| ROICexgc | 52.34% | ||
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% | ||
| FCFM | 30.78% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score8
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Debt/EBITDA | 1.1 | ||
| Cap/Depr | 82.91% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.34% | ||
| Profit Quality | 185.99% | ||
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 | ||
| Altman-Z | 6.26 |
F-Score8
WACC8.35%
ROIC/WACC2.27
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
EPS Next Y0.57%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
EBIT growth 1Y-5.08%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year4.08%
EBIT Next 3Y11.97%
EBIT Next 5YN/A
FCF growth 1Y32.98%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y38.18%
OCF growth 3Y116.21%
OCF growth 5Y46.62%